Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:26 AM
NCT ID:
NCT01317420
Pre Assignment Details:
All subjects were screened for eligibility prior to participation in the trial. Subjects attended a specialist site which ensured that they (the subjects) strictly met all inclusion and none of the exclusion criteria. Subjects were not to be allocated to a treatment group if any of the entry criteria were violated.
Recruitment Details:
Open label, uncontrolled, dose escalation, 3+3 design, and multicenter study in two parts. Part 1: dose escalation in patients with advanced solid tumours to determine the MTD or RBD. Part 2: expansion part at the RBD in patients with selected tumour types more likely to benefit from BI 836845 (Cohort 1- Ewing's family of tumours or PNET; Cohort 2 - biopsiable solid tumours) in order to investigate safety and PK/pharmacodynamics.
Study:
NCT01317420
Study Brief:
Results Section:
NCT01317420